Interferons in renal-cell carcinoma: status and prospects.
De Mulder
P H
PH
Department of Medical Oncology, University Hospital Nijmegen, The Netherlands.
Debruyne
F M
FM
Beniers
A J
AJ
D000818:Animals; D002292:Carcinoma, Renal Cell / Q000601:surgery / Q000628:therapy*; D003131:Combined Modality Therapy; D004341:Drug Evaluation; D004354:Drug Screening Assays, Antitumor; D004357:Drug Synergism; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D007370:Interferon Type I / Q000627:therapeutic use; D007372:Interferons / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000601:surgery / Q000628:therapy*; D009392:Nephrectomy; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins
D007155:Immunologic Factors; D007370:Interferon Type I; D011994:Recombinant Proteins; D007372:Interferons